Coursera Spring Sale
40% Off Coursera Plus Annual!
Grab it
Join this expert panel webinar to explore how biomarkers have evolved from exploratory tools into strategic assets that are transforming drug development and clinical trials. Learn from industry thought leaders representing major pharmaceutical companies including Johnson & Johnson Innovative Medicine, AstraZeneca R&D, and Takeda Pharmaceuticals, alongside proteomics expertise from Thermo Fisher Scientific, as they discuss the integration of biomarkers across the entire drug development pipeline. Discover strategies for leveraging biomarkers to reduce development risks, improve success rates, accelerate timelines, and enhance patient outcomes in modern pharmaceutical research. Gain insights into translational sciences, immunology applications, cardiovascular and metabolic research, liver disease biomarkers, and proteomics approaches that are shaping the future of precision medicine and clinical trial design.
